Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun;184(6):992-993.
doi: 10.1111/bjd.19696. Epub 2020 Dec 21.

Head-to-head comparison of biologics in psoriasis: better acceleration does not necessarily win all races

L Puig  1
Affiliations
Comment

Head-to-head comparison of biologics in psoriasis: better acceleration does not necessarily win all races

L Puig. Br J Dermatol. 2021 Jun.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Blauvelt A, Leonardi C, Elewski B et al.; IXORA-R Study Group. A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial. Br J Dermatol 2020. https://doi.org/10.1111/bjd.19509.
    1. Blauvelt A, Papp K, Gottlieb A et al. IXORA-R Study Group. A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial. Br J Dermatol 2020; 182:1348-58.
    1. Gottlieb AB, Saure D, Wilhelm S et al. Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12. J Dermatol Treat 2020; https://doi.org/10.1080/09546634.2020.1747592.
    1. Warren RB, See K, Burge R et al. Rapid response of biologic treatments of moderate-to-severe plaque psoriasis: a comprehensive investigation using Bayesian and Frequentist network meta-analyses. Dermatol Ther 2020; 10:73-86.
    1. McGonagle D. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol JEADV 2009; 23 (Suppl. 1):9-13.